[QT dispersion]. 1996

A Bańcarz, and M Kobusiak-Prokopowicz
Katedry i Kliniki Kardiologii, Akademii Medycznej we Wrocławiu.

The study presents the modern concepts on QT dispersion which is regarded as one of the reasons of potentially dangerous cardiac arrhythmias. The measurement of QT interval is based on standard 12-lead electrocardiogram or 24-hours Holter monitoring record. The study describes the rules of QT dispersion measurement and the most common problems connected with it. The changes of QT dispersion in ischaemic heart disease, heart failure, cardiac arrhythmia and prolonged QT interval syndrome were discussed. The study presents also the influence of such drugs as amiodarone, sotalol, beta-adrenolytics on QT dispersion. It was found out that QT dispersion measurement in patients with cardiac diseases seems to be the easy predictor of life-threatening cardiac arrhythmias. The problem is still very controversial and needs further clinical investigations.

UI MeSH Term Description Entries
D008133 Long QT Syndrome A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME. Electrocardiogram QT Prolonged
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015716 Electrocardiography, Ambulatory Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia. Ambulatory Electrocardiography,Electrocardiography, Dynamic,Electrocardiography, Holter,Holter ECG,Holter EKG,Holter Monitoring,Monitoring, Ambulatory Electrocardiographic,Monitoring, Holter,Ambulatory Electrocardiography Monitoring,Dynamic Electrocardiography,Electrocardiography Monitoring, Ambulatory,Holter Electrocardiography,Ambulatory Electrocardiographic Monitoring,ECG, Holter,ECGs, Holter,EKG, Holter,EKGs, Holter,Electrocardiographic Monitoring, Ambulatory,Holter ECGs,Holter EKGs,Monitoring, Ambulatory Electrocardiography

Related Publications

A Bańcarz, and M Kobusiak-Prokopowicz
June 1994, British heart journal,
A Bańcarz, and M Kobusiak-Prokopowicz
January 1998, Journal of electrocardiology,
A Bańcarz, and M Kobusiak-Prokopowicz
August 2001, Ceskoslovenska fysiologie,
A Bańcarz, and M Kobusiak-Prokopowicz
March 1997, Lancet (London, England),
A Bańcarz, and M Kobusiak-Prokopowicz
January 2011, Swiss medical weekly,
A Bańcarz, and M Kobusiak-Prokopowicz
October 2005, Chest,
A Bańcarz, and M Kobusiak-Prokopowicz
November 1998, Heart (British Cardiac Society),
A Bańcarz, and M Kobusiak-Prokopowicz
May 2003, The American journal of cardiology,
A Bańcarz, and M Kobusiak-Prokopowicz
December 1999, International journal of cardiology,
A Bańcarz, and M Kobusiak-Prokopowicz
January 2000, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!